Custom Carbon-14 Radiolabelling: investing to meet new challenges. Winter 09
By Dave Roberts
One consequence of an increasing demand from regulators for robust quantitative data on the behaviour of new drugs in man and for information on the fate of pharmaceuticals in the environ...

